Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells

Takashi Yuri, Reiko Tsukamoto, Katsuaki Miki, Norihisa Uehara, Yoichiro Matsuoka, Airo Tsubura

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Zeranol (α-zearalanol) is a metabolite of the mycoestrogen zearalenone, and is used as a growth promoter of livestock due to its strong estrogenic activity. In the present study, we investigated the effects of zeranol on the growth of estrogen receptor (ER)-positive and -negative human breast carcinoma cells in vitro, and the molecules involved. At low concentrations, zeranol accelerated the growth of ER-positive MCF-7 and KPL-1 human breast carcinoma cells, but did not affect the growth of ER-negative MDA-MB-231 cells. At high concentrations, zeranol suppressed the growth of both ER-positive and -negative human breast carcinoma cells. The acceleration of ER-positive cell growth by low-dose zeranol involved the down-regulation of p21Cip1 (a cyclin-dependent kinase inhibitor), which resulted in cell cycle progression. High-dose zeranol induced the formation of a sub-G1 fraction and the up-regulation of the apoptosis stimulator p53, suggesting the induction of apoptosis. Thus, zeranol exerted dose-dependent biphasic effects on ER-positive human breast carcinoma cells, accelerating cell growth at low concentrations and inducing apoptosis at high concentrations.

Original languageEnglish
Pages (from-to)1307-1312
Number of pages6
JournalOncology reports
Volume16
Issue number6
Publication statusPublished - Dec 1 2006
Externally publishedYes

Fingerprint

Zeranol
Estrogen Receptors
Breast Neoplasms
Growth
Apoptosis
Zearalenone
Cyclin-Dependent Kinases
Livestock
Cell Cycle
Up-Regulation
Down-Regulation

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

Yuri, T., Tsukamoto, R., Miki, K., Uehara, N., Matsuoka, Y., & Tsubura, A. (2006). Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells. Oncology reports, 16(6), 1307-1312.

Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells. / Yuri, Takashi; Tsukamoto, Reiko; Miki, Katsuaki; Uehara, Norihisa; Matsuoka, Yoichiro; Tsubura, Airo.

In: Oncology reports, Vol. 16, No. 6, 01.12.2006, p. 1307-1312.

Research output: Contribution to journalArticle

Yuri, T, Tsukamoto, R, Miki, K, Uehara, N, Matsuoka, Y & Tsubura, A 2006, 'Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells', Oncology reports, vol. 16, no. 6, pp. 1307-1312.
Yuri, Takashi ; Tsukamoto, Reiko ; Miki, Katsuaki ; Uehara, Norihisa ; Matsuoka, Yoichiro ; Tsubura, Airo. / Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells. In: Oncology reports. 2006 ; Vol. 16, No. 6. pp. 1307-1312.
@article{ea8e9359e9dc4aa5ae7d218b03b8956b,
title = "Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells",
abstract = "Zeranol (α-zearalanol) is a metabolite of the mycoestrogen zearalenone, and is used as a growth promoter of livestock due to its strong estrogenic activity. In the present study, we investigated the effects of zeranol on the growth of estrogen receptor (ER)-positive and -negative human breast carcinoma cells in vitro, and the molecules involved. At low concentrations, zeranol accelerated the growth of ER-positive MCF-7 and KPL-1 human breast carcinoma cells, but did not affect the growth of ER-negative MDA-MB-231 cells. At high concentrations, zeranol suppressed the growth of both ER-positive and -negative human breast carcinoma cells. The acceleration of ER-positive cell growth by low-dose zeranol involved the down-regulation of p21Cip1 (a cyclin-dependent kinase inhibitor), which resulted in cell cycle progression. High-dose zeranol induced the formation of a sub-G1 fraction and the up-regulation of the apoptosis stimulator p53, suggesting the induction of apoptosis. Thus, zeranol exerted dose-dependent biphasic effects on ER-positive human breast carcinoma cells, accelerating cell growth at low concentrations and inducing apoptosis at high concentrations.",
author = "Takashi Yuri and Reiko Tsukamoto and Katsuaki Miki and Norihisa Uehara and Yoichiro Matsuoka and Airo Tsubura",
year = "2006",
month = "12",
day = "1",
language = "English",
volume = "16",
pages = "1307--1312",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "6",

}

TY - JOUR

T1 - Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells

AU - Yuri, Takashi

AU - Tsukamoto, Reiko

AU - Miki, Katsuaki

AU - Uehara, Norihisa

AU - Matsuoka, Yoichiro

AU - Tsubura, Airo

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Zeranol (α-zearalanol) is a metabolite of the mycoestrogen zearalenone, and is used as a growth promoter of livestock due to its strong estrogenic activity. In the present study, we investigated the effects of zeranol on the growth of estrogen receptor (ER)-positive and -negative human breast carcinoma cells in vitro, and the molecules involved. At low concentrations, zeranol accelerated the growth of ER-positive MCF-7 and KPL-1 human breast carcinoma cells, but did not affect the growth of ER-negative MDA-MB-231 cells. At high concentrations, zeranol suppressed the growth of both ER-positive and -negative human breast carcinoma cells. The acceleration of ER-positive cell growth by low-dose zeranol involved the down-regulation of p21Cip1 (a cyclin-dependent kinase inhibitor), which resulted in cell cycle progression. High-dose zeranol induced the formation of a sub-G1 fraction and the up-regulation of the apoptosis stimulator p53, suggesting the induction of apoptosis. Thus, zeranol exerted dose-dependent biphasic effects on ER-positive human breast carcinoma cells, accelerating cell growth at low concentrations and inducing apoptosis at high concentrations.

AB - Zeranol (α-zearalanol) is a metabolite of the mycoestrogen zearalenone, and is used as a growth promoter of livestock due to its strong estrogenic activity. In the present study, we investigated the effects of zeranol on the growth of estrogen receptor (ER)-positive and -negative human breast carcinoma cells in vitro, and the molecules involved. At low concentrations, zeranol accelerated the growth of ER-positive MCF-7 and KPL-1 human breast carcinoma cells, but did not affect the growth of ER-negative MDA-MB-231 cells. At high concentrations, zeranol suppressed the growth of both ER-positive and -negative human breast carcinoma cells. The acceleration of ER-positive cell growth by low-dose zeranol involved the down-regulation of p21Cip1 (a cyclin-dependent kinase inhibitor), which resulted in cell cycle progression. High-dose zeranol induced the formation of a sub-G1 fraction and the up-regulation of the apoptosis stimulator p53, suggesting the induction of apoptosis. Thus, zeranol exerted dose-dependent biphasic effects on ER-positive human breast carcinoma cells, accelerating cell growth at low concentrations and inducing apoptosis at high concentrations.

UR - http://www.scopus.com/inward/record.url?scp=35648986968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35648986968&partnerID=8YFLogxK

M3 - Article

C2 - 17089054

AN - SCOPUS:35648986968

VL - 16

SP - 1307

EP - 1312

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 6

ER -